© 2020 Institute of Physics and Engineering in Medicine. BrachyView is a novel in-body imaging system developed to provide real-time intraoperative dosimetry for low dose rate prostate brachytherapy treatments. Seed positions can be reconstructed after in-vivo implantation using a high-resolution pinhole gamma camera inserted into the patient rectum. The obtained data is a set of 2D projections of the seeds on the image plane. The 3D reconstruction algorithm requires the identification of the seed\u27s centre of mass. This work presents the development and techniques adopted to build an algorithm that provides the means for fully automatic seed centre of mass identification and 3D position reconstruction for real-time applications. The algo...
PURPOSE: An MR-only postimplant dosimetry workflow for low dose rate (LDR) brachytherapy could reduc...
A transrectal real-time source tracking system, BrachyView, is developed by Centre for Medical Radia...
Prostate cancer is the second most common cancer in men and the second-leading cause of cancer death...
Purpose: BrachyView is a novel in-body imaging system developed with the objective to provide real-t...
Purpose: The conformity of the achieved dose distribution to the treatment plan strongly correlates ...
Purpose BrachyView is a novel in-body imaging system which aims to provide LDR brachytherapy seeds p...
BrachyView is a novel in-body imaging system, aimed to accurately localise brachytherapy sources usi...
BrachyView is a novel in-body imaging system developed with the objective to provide real-time intra...
Brachytherapy is an important therapeutic modality in modern cancer treatments. HDR Brachytherapy in...
Prostate cancer is quickly becoming the most common form of cancer across the globe, and is commonly...
Motivation: In prostate brachytherapy, intra-operative dosimetry would be ideal to allow for rapid e...
Motivation: In prostate brachytherapy, transrectal ultrasound (TRUS) is used to visualize the anatom...
Errors in seed placement during low dose rate prostate brachytherapy can result in over-treating hea...
Intraoperative dosimetry in prostate brachytherapy requires localization of the implanted radioactiv...
Prostate brachytherapy is a widely used treatment of localized prostate cancer. Intra-operative dose...
PURPOSE: An MR-only postimplant dosimetry workflow for low dose rate (LDR) brachytherapy could reduc...
A transrectal real-time source tracking system, BrachyView, is developed by Centre for Medical Radia...
Prostate cancer is the second most common cancer in men and the second-leading cause of cancer death...
Purpose: BrachyView is a novel in-body imaging system developed with the objective to provide real-t...
Purpose: The conformity of the achieved dose distribution to the treatment plan strongly correlates ...
Purpose BrachyView is a novel in-body imaging system which aims to provide LDR brachytherapy seeds p...
BrachyView is a novel in-body imaging system, aimed to accurately localise brachytherapy sources usi...
BrachyView is a novel in-body imaging system developed with the objective to provide real-time intra...
Brachytherapy is an important therapeutic modality in modern cancer treatments. HDR Brachytherapy in...
Prostate cancer is quickly becoming the most common form of cancer across the globe, and is commonly...
Motivation: In prostate brachytherapy, intra-operative dosimetry would be ideal to allow for rapid e...
Motivation: In prostate brachytherapy, transrectal ultrasound (TRUS) is used to visualize the anatom...
Errors in seed placement during low dose rate prostate brachytherapy can result in over-treating hea...
Intraoperative dosimetry in prostate brachytherapy requires localization of the implanted radioactiv...
Prostate brachytherapy is a widely used treatment of localized prostate cancer. Intra-operative dose...
PURPOSE: An MR-only postimplant dosimetry workflow for low dose rate (LDR) brachytherapy could reduc...
A transrectal real-time source tracking system, BrachyView, is developed by Centre for Medical Radia...
Prostate cancer is the second most common cancer in men and the second-leading cause of cancer death...